97 related articles for article (PubMed ID: 21067263)
1. EGFR and HER-2 status of non-small cell lung cancer brain metastasis and corresponding primary tumor.
Koo JS; Kim SH
Neoplasma; 2011; 58(1):27-34. PubMed ID: 21067263
[TBL] [Abstract][Full Text] [Related]
2. Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer.
Simone G; Mangia A; Malfettone A; Rubini V; Siciliano M; Di Benedetto A; Terrenato I; Novelli F; Mottolese M
J Exp Clin Cancer Res; 2010 Sep; 29(1):125. PubMed ID: 20843314
[TBL] [Abstract][Full Text] [Related]
3. HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.
Sun M; Behrens C; Feng L; Ozburn N; Tang X; Yin G; Komaki R; Varella-Garcia M; Hong WK; Aldape KD; Wistuba II
Clin Cancer Res; 2009 Aug; 15(15):4829-37. PubMed ID: 19622585
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors.
Italiano A; Vandenbos FB; Otto J; Mouroux J; Fontaine D; Marcy PY; Cardot N; Thyss A; Pedeutour F
Ann Oncol; 2006 Jun; 17(6):981-5. PubMed ID: 16524970
[TBL] [Abstract][Full Text] [Related]
5. Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites.
Bozzetti C; Tiseo M; Lagrasta C; Nizzoli R; Guazzi A; Leonardi F; Gasparro D; Spiritelli E; Rusca M; Carbognani P; Majori M; Franciosi V; Rindi G; Ardizzoni A
J Thorac Oncol; 2008 Jan; 3(1):18-22. PubMed ID: 18166836
[TBL] [Abstract][Full Text] [Related]
6. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.
Tan D; Deeb G; Wang J; Slocum HK; Winston J; Wiseman S; Beck A; Sait S; Anderson T; Nwogu C; Ramnath N; Loewen G
Diagn Mol Pathol; 2003 Dec; 12(4):201-11. PubMed ID: 14639106
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis.
Xu YJ; Shao YF; Zhao X; Geng YT; Wang K; Yin YM
J Cancer Res Clin Oncol; 2011 Dec; 137(12):1841-8. PubMed ID: 21927908
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer.
Daniele L; Cassoni P; Bacillo E; Cappia S; Righi L; Volante M; Tondat F; Inghirami G; Sapino A; Scagliotti GV; Papotti M; Novello S
J Thorac Oncol; 2009 Jun; 4(6):684-8. PubMed ID: 19404216
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor status in breast cancer metastases to the central nervous system. Comparison with HER-2/neu status.
Grupka NL; Lear-Kaul KC; Kleinschmidt-DeMasters BK; Singh M
Arch Pathol Lab Med; 2004 Sep; 128(9):974-9. PubMed ID: 15335267
[TBL] [Abstract][Full Text] [Related]
10. Frequent overexpression of ErbB--receptor family members in brain metastases of non-small cell lung cancer patients.
Berghoff AS; Magerle M; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckman K; Marosi C; Wöhrer A; Hackl M; Zöchbauer-Müller S; Preusser M; Birner P
APMIS; 2013 Dec; 121(12):1144-52. PubMed ID: 23756255
[TBL] [Abstract][Full Text] [Related]
11. p185(HER-2/neu) and p21(CIP1/WAF1) expression in primary tumors and lymph node metastases in non-small cell lung cancer.
Akita K; Inagaki H; Sato S; Niimi T; Maeda H; Ninomiya S; Achiwa H; Kawaguchi H; Yamakawa Y; Fujii Y; Shimizu S; Eimoto T; Ueda R
Jpn J Cancer Res; 2002 Sep; 93(9):1007-11. PubMed ID: 12359054
[TBL] [Abstract][Full Text] [Related]
12. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections.
Pfeiffer P; Clausen PP; Andersen K; Rose C
Br J Cancer; 1996 Jul; 74(1):86-91. PubMed ID: 8679464
[TBL] [Abstract][Full Text] [Related]
13. HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer.
Brattström D; Wester K; Bergqvist M; Hesselius P; Malmström PU; Nordgren H; Wagenius G; Brodin O
Acta Oncol; 2004; 43(1):80-6. PubMed ID: 15068324
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Her-2, EGFR and cyclin D1 in primary breast cancer and paired metastatic lymph nodes: an immunohistochemical and chromogenic in situ hybridization study.
Cho EY; Han JJ; Choi YL; Kim KM; Oh YL
J Korean Med Sci; 2008 Dec; 23(6):1053-61. PubMed ID: 19119452
[TBL] [Abstract][Full Text] [Related]
15. [Differential expressions of MDR-1, RRM-1, EGFR and ERCC-1 in primary tumors and metastatic lymph nodes of NSCLC patients].
Guo N; Li S; Zhang W; Yu C; Wang H; Zhang Y; Yu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):870-3. PubMed ID: 23948418
[TBL] [Abstract][Full Text] [Related]
16. Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study.
Ooi A; Takehana T; Li X; Suzuki S; Kunitomo K; Iino H; Fujii H; Takeda Y; Dobashi Y
Mod Pathol; 2004 Aug; 17(8):895-904. PubMed ID: 15143334
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
Aiko N; Shimokawa T; Miyazaki K; Misumi Y; Agemi Y; Ishii M; Nakamura Y; Yamanaka T; Okamoto H
BMC Cancer; 2018 Oct; 18(1):1012. PubMed ID: 30348116
[TBL] [Abstract][Full Text] [Related]
18. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A
Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203
[TBL] [Abstract][Full Text] [Related]
19. The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.
Liu L; Shao X; Gao W; Bai J; Wang R; Huang P; Yin Y; Liu P; Shu Y
J Thorac Oncol; 2010 Dec; 5(12):1922-32. PubMed ID: 21155183
[TBL] [Abstract][Full Text] [Related]
20. Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC.
Cappuzzo F; Gregorc V; Rossi E; Cancellieri A; Magrini E; Paties CT; Ceresoli G; Lombardo L; Bartolini S; Calandri C; de Rosa M; Villa E; Crino L
J Clin Oncol; 2003 Jul; 21(14):2658-63. PubMed ID: 12860941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]